These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21315408

  • 1. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
    Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J.
    Hum Pathol; 2011 Jul; 42(7):1019-26. PubMed ID: 21315408
    [Abstract] [Full Text] [Related]

  • 2. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
    Davidson B, Shih IeM, Wang TL.
    Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B.
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [Abstract] [Full Text] [Related]

  • 6. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.
    Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM.
    Hum Pathol; 2011 Jul; 42(7):991-7. PubMed ID: 21315424
    [Abstract] [Full Text] [Related]

  • 9. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
    Roque DM, Bellone S, Buza N, Romani C, Cocco E, Bignotti E, Ravaggi A, Rutherford TJ, Schwartz PE, Pecorelli S, Santin AD.
    Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
    [Abstract] [Full Text] [Related]

  • 10. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.
    Leskelä S, Leandro-García LJ, Mendiola M, Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo A, de Santiago J, Robledo M, Hardisson D, Rodríguez-Antona C.
    Endocr Relat Cancer; 2011 Feb; 18(1):85-95. PubMed ID: 21051560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B.
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [Abstract] [Full Text] [Related]

  • 14. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 16. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
    Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B.
    Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
    [Abstract] [Full Text] [Related]

  • 17. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
    Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B.
    Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
    [Abstract] [Full Text] [Related]

  • 18. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.
    Kleinberg L, Holth A, Trope CG, Reich R, Davidson B.
    Hum Pathol; 2008 May; 39(5):747-57. PubMed ID: 18439941
    [Abstract] [Full Text] [Related]

  • 19. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [Abstract] [Full Text] [Related]

  • 20. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
    Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP.
    Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.